Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation.
Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation.
复制标题
DOI:
10.1038/s41590-022-01289-w
复制
发表时间:
2022-09
影响因子:
30.5
通讯作者:
Sansom, David M.
中科院分区:
文献类型:
--
作者:
Kennedy, Alan;Waters, Erin;Rowshanravan, Behzad;Hinze, Claudia;Williams, Cayman;Janman, Daniel;Fox, Thomas A.;Booth, Claire;Pesenacker, Anne M.;Halliday, Neil;Soskic, Blagoje;Kaur, Satdip;Qureshi, Omar S.;Morris, Emma C.;Ikemizu, Shinji;Paluch, Christopher;Huo, Jiandong;Davis, Simon J.;Boucrot, Emmanuel;Walker, Lucy S. K.;Sansom, David M.
CD28 and CTLA-4 (CD152) play essential roles in regulating T cell immunity, balancing the activation and inhibition of T cell responses, respectively. Although both receptors share the same ligands, CD80 and CD86, the specific requirement for two distinct ligands remains obscure. In the present study, we demonstrate that, although CTLA-4 targets both CD80 and CD86 for destruction via transendocytosis, this process results in separate fates for CTLA-4 itself. In the presence of CD80, CTLA-4 remained ligand bound, and was ubiquitylated and trafficked via late endosomes and lysosomes. In contrast, in the presence of CD86, CTLA-4 detached in a pH-dependent manner and recycled back to the cell surface to permit further transendocytosis. Furthermore, we identified clinically relevant mutations that cause autoimmune disease, which selectively disrupted CD86 transendocytosis, by affecting either CTLA-4 recycling or CD86 binding. These observations provide a rationale for two distinct ligands and show that defects in CTLA-4-mediated transendocytosis of CD86 are associated with autoimmunity. The inhibitory receptor CTLA-4 recognizes two ligands on opposing antigen-presenting cells, CD80 and CD86. Sansom and colleagues show CTLA-4 captures ligands by transendocytosis, whereupon low-affinity CD86 releases CTLA-4 at low pH to promote CTLA-4 recycling; however, high-affinity CD80 remains bound and targets CTLA-4 for ubiquitination and destruction.
登录
查看更多内容
影响因子:
30.5
作者:
通讯作者:
--
DOI:
10.1084/jem.180.2.631
发表时间:
1994-08-01
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Hathcock KS;Laszlo G;Pucillo C;Linsley P;Hodes RJ
通讯作者:
Hodes RJ
DOI:
10.1126/science.1202947
发表时间:
2011-04-29
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Qureshi OS;Zheng Y;Nakamura K;Attridge K;Manzotti C;Schmidt EM;Baker J;Jeffery LE;Kaur S;Briggs Z;Hou TZ;Futter CE;Anderson G;Walker LS;Sansom DM
通讯作者:
Sansom DM
DOI:
10.4049/jimmunol.1102885
发表时间:
2012-05-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Good-Jacobson KL;Song E;Anderson S;Sharpe AH;Shlomchik MJ
通讯作者:
Shlomchik MJ
影响因子:
14.8
作者:
通讯作者:
--